Policy Brief
⭐ 4.6
Biostatistics Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A difference-in-differences analysis
Abstract
This policy brief investigates “Biostatistics Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A difference-in-differences analysis” using a agent-based simulation. Through a economic lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.